Use of smooth muscle markers is better than the endothelial cell markers for identification of tumor venous invasion and extramural tumor deposits in gastrointestinal tract tumors.
Das P, Baloda V.
Indian J Pathol Microbiol. 2020 Jan-Mar;63(1):3-4. doi: 10.4103/IJPM.IJPM_284_19.
PMID:32031113
Clinical and endoscopic aspects of metastases to the gastrointestinal tract.
Haendchen Bento L, Kazuyoshi Minata M, Pires Batista C, Martins BDC, Lenz Tolentino LH, Scomparim RC, Shiguehissa Kawaguti F, Gusmon de Oliveira CC, Simas de Lima M, Naschold Geiger S, Ryoka Baba E, Safatle-Ribeiro A, Ribeiro U Jr, Maluf-Filho F.
Endoscopy. 2019 Jul;51(7):646-652. doi: 10.1055/a-0887-4401. Epub 2019 May 14.
PMID:31087306
F-18 FDG PET/CT findings of metastatic ovarian tumors from gastrointestinal tract origin.
Park HL, Yoo IeR, O JH, Han EJ, Kim SH.
J Cancer Res Clin Oncol. 2015 Oct;141(10):1871-8. doi: 10.1007/s00432-015-1978-2. Epub 2015 May 3.
PMID:25935146
The Tipping Point: Key Oncologic Imaging Findings Resulting in Critical Changes in the Management of Malignant Tumors of the Gastrointestinal Tract.